Search research articles
Contact Us
Filters
Showing results (51-60 of 58) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 58 results.
Journal of Lipid Research
|
March 19, 2017
Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and E
John S Millar, Michael E Lassman, Tiffany Thomas, et al.
Journal of the American College of Cardiology
|
April 16, 2021
Gaining Efficiency in Clinical Trials With Cardiac Biomarkers: JACC Review Topic of the Week
James L Januzzi, John M Canty, Saumya Das, et al.
The Journal of Clinical Investigation
|
May 12, 2015
Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects
John S Millar, Gissette Reyes-Soffer, Patricia Jumes, et al.
The Journal of Clinical Investigation
|
April 2, 2016
Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects
John S Millar, Gissette Reyes-Soffer, Patricia Jumes, et al.
Blood
|
June 11, 2026
Anticoagulation with mechanistically distinct FXI/FXIa antibodies amrecibart (REGN9933A2) and cenvacibart (REGN7508Cat)
Dan Chalothorn, Aaron Paul Kithcart, Ethan Marin, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
March 12, 2016
Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer Protein
Gissette Reyes-Soffer, John S Millar, Colleen Ngai, et al.
The New England Journal of Medicine
|
July 2, 2021
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
Julian D Gillmore, Ed Gane, Jorg Taubel, et al.
American Heart Journal
|
December 1, 2012
Cardiac imaging approaches to evaluate drug-induced myocardial dysfunction
Jennifer B Christian, John K Finkle, Bonnie Ky, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 58) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 58 results.
Journal of Lipid Research
|
March 19, 2017
Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and E
John S Millar, Michael E Lassman, Tiffany Thomas, et al.
Journal of the American College of Cardiology
|
April 16, 2021
Gaining Efficiency in Clinical Trials With Cardiac Biomarkers: JACC Review Topic of the Week
James L Januzzi, John M Canty, Saumya Das, et al.
The Journal of Clinical Investigation
|
May 12, 2015
Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects
John S Millar, Gissette Reyes-Soffer, Patricia Jumes, et al.
The Journal of Clinical Investigation
|
April 2, 2016
Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects
John S Millar, Gissette Reyes-Soffer, Patricia Jumes, et al.
Blood
|
June 11, 2026
Anticoagulation with mechanistically distinct FXI/FXIa antibodies amrecibart (REGN9933A2) and cenvacibart (REGN7508Cat)
Dan Chalothorn, Aaron Paul Kithcart, Ethan Marin, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
March 12, 2016
Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer Protein
Gissette Reyes-Soffer, John S Millar, Colleen Ngai, et al.
The New England Journal of Medicine
|
July 2, 2021
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
Julian D Gillmore, Ed Gane, Jorg Taubel, et al.
American Heart Journal
|
December 1, 2012
Cardiac imaging approaches to evaluate drug-induced myocardial dysfunction
Jennifer B Christian, John K Finkle, Bonnie Ky, et al.
Page
of 6